Internet-based, Naturalistic Evaluation of Tolerability and Individual Patient Target Pressures With Bimatoprost 0.03% in Glaucoma
NCT00487214 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 361
Last updated 2011-06-01
Summary
The purpose of this study is to evaluate the range of target IOPs set for glaucoma patients starting monotherapy with bimatoprost and to evaluate patient and physician satisfaction with bimatoprost in "real-world" settings
Conditions
- Glaucoma, Open-Angle
Sponsors & Collaborators
-
Allergan
lead INDUSTRY
Principal Investigators
-
Medical Affairs · Allergan
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-06-30
- Primary Completion
- 2003-02-28
- Completion
- 2003-02-28
More Related Trials
-
A Safety Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension
NCT01830140 ·Status: COMPLETED ·Phase: PHASE3
-
Tolerability of Bimatoprost 0.01% vs Latanoprost Eye Drops
NCT02138461 ·Status: COMPLETED
-
A Study of 0.03% Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension
NCT02020512 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
NCT01157364 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension
NCT02636946 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Different Formulations of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
NCT01099774 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of Bimatoprost, Latanoprost, and Travoprost in Patients With Elevated Intraocular Pressure (IOP) and Open-angle Glaucoma (OAG)
NCT00716742 ·Status: COMPLETED
-
A Study of Bimatoprost 0.01% in the Clinical Setting
NCT01814761 ·Status: COMPLETED
-
Efficacy and Safety Study of Bimatoprost Sustained-Release (SR) in Participants With Open-angle Glaucoma or Ocular Hypertension
NCT02247804 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension
NCT02250651 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of Different Formulations of Bimatoprost Once-Daily in Patients With Glaucoma or Ocular Hypertension
NCT00652496 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Safety and Efficacy of Bimatoprost in Patients With Glaucoma or Ocular Hypertension
NCT00538304 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of Bimatoprost in Ethnically Japanese Patients With Open-Angle Glaucoma or Ocular Hypertension
NCT00651859 ·Status: COMPLETED ·Phase: PHASE2
-
24-hour IOP-lowering Effect of 0.01% Bimatoprost
NCT01271686 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Bimatoprost/Timolol Fixed Combination Versus Latanoprost in Patients With Open-Angle Glaucoma Who Have Never Been Treated
NCT01243567 ·Status: COMPLETED ·Phase: PHASE4
-
Bimatoprost Monotherapy vs. Dual Therapy With Travoprost and Timolol in Patients With Glaucoma and Ocular Hypertension
NCT00348023 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Bimatoprost and Latanoprost in Patients With Chronic Angle-Closure Glaucoma: A Randomized Cross-Over Study
NCT00567788 ·Status: UNKNOWN ·Phase: NA
-
A Safety and Efficacy Study of Fixed-Combination Bimatoprost and Brimonidine in Chronic Glaucoma or Ocular Hypertension
NCT01863953 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-angle Glaucoma or Ocular Hypertension Patients
NCT00069706 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Bimatoprost Sustained Release (SR) to Selective Laser Trabeculoplasty (SLT) in Adults With Open-Angle Glaucoma or Ocular Hypertension
NCT02507687 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of a Drug Delivery System in Glaucoma
NCT01016691 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of AGN-210961 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
NCT01110499 ·Status: COMPLETED ·Phase: PHASE2
-
Determination Of Predictive Factors Allowing To An Additional 10% Reduction Of Intra-Ocular Pressure
NCT00230763 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Comparing IOP-Lowering Treatments to Bimatoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
NCT01646151 ·Status: COMPLETED
-
Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005%
NCT00440011 ·Status: COMPLETED ·Phase: PHASE4